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Abstract Hydrogen sulphide (H2S) has been recently 
proposed as a transmitter in the brain and peripheral 
tissues. Its role in the gastrointestinal tract is still 
unknown despite some data which suggest an 
involvement mediating smooth muscle relaxation. 
The aim of this study was to investigate the effect of 
this gas on intestinal segments from mouse jejunum 
and colon, and muscular strips from the human and 
rat colon. In isolated segments of mouse colon and 
jejunum, bath applied sodium hydrogen sulphide 
(NaHS) (a H2S donor) caused a concentration-depen­
dent inhibition of spontaneous motor complexes 
(MCs) (IC50 121 lmol L
)1 in the colon and 
150 lmol L)1 in the jejunum). This inhibitory effect of 
NaHS on MCs was (i) unaffected by tetrodotoxin 
(TTX), capsaicin, pyridoxal-phosphate-6-azophenyl­
2¢,4¢-disulfonate and N-nitro-L-arginine suggesting a 
non-neural effect and (ii) signiﬁcantly reduced by 
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apamin 3 lmol L)1. NaHS concentration-dependently 
inhibited the spontaneous motility in strips from 
human colon (IC50 261 lmol L
)1) and rat colon (IC50 
31 lmol L)1). The inhibitory effect of NaHS on colonic 
strips was (i) unaffected by the neural blocker TTX 
(1 lmol L)1) with IC50 183 lmol L
)1 for the human 
colon and of 26 lmol L)1 for the rat colon and (ii) 
signiﬁcantly reduced by glybenclamide (10 lmol L)1), 
apamin (3 lmol L)1) and TEA (10 mmol L)1) with 
IC50 values of 2464, 1307 and 2421 lmol L
)1 for 
human strips, and 80, 167 and 674 lmol L)1 for rat 
strips respectively. We conclude that H2S strongly 
inhibits in vitro intestinal and colonic motor patterns. 
This effect appears to be critically dependent on K 
channels particularly apamin-sensitive SK channels 
and glybenclamide-sensitive K (ATP) channels. 
Keywords cystathionine b-synthase, cystathionine 
c-lyase, gastrointestinal tract, hydrogen sulphide, 
potassium channels, smooth muscle. 
INTRODUCTION 
The foul smelling gas, hydrogen sulphide (H2S) has been 
proposed as a third gaseous neuromodulator, after nitric 
oxide (NO) and carbon monoxide (CO). H2S can be 
produced via the reduction of the amino acid cysteine 
through two endogenous enzyme systems. The ﬁrst 
enzyme is cystathionine b-synthase (CBS) which is 
present in brain and peripheral tissues, including the 
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gut.1 The second enzyme is cystathionine c-lyase (CSE), 
found only in peripheral tissues.2,3 Both CBS and CSE 
have been found in enteric neurons.4 In addition, a third, 
non-pyridoxal-phosphate-dependent enzyme, merca­
ptopyruvate sulfurtransferase, has been proposed as a 
hydrogen sulﬁde-generating enzyme.5 H2S could be 
generated through non-enzymatic reactions as it has 
been shown that washed human erythrocytes incubated 
with glucose and elemental sulphur produce H2S at a  
constant rate. As sulphur and glucose are both available 
in circulating blood, this is a possible pathway of 
production in vivo.6 In addition, large quantities of H2S 
are produced by endogenous sulphate reducing bacteria 
in the gastrointestinal (GI) tract, and concentrations can 
reach 3 mmol L)1 in the colon.7 
Emerging evidence indicates that H2S can have 
major effects on excitable tissues, such as nerves and 
smooth muscle.8–11 In the urinary bladder, Pataccini 
et al.12 have demonstrated an excitatory action of H2S 
on bladder contraction, which was mediated by capsa­
icin sensitive nerves. In contrast, H2S caused relaxa­
tion in isolated ileal muscle strips.13 In vascular 
smooth muscle, H2S has been shown to facilitate the 
release of NO, acting in synergy with endogenously 
released NO to cause relaxation.14 Recent work by 
Shichio et al. 4 has demonstrated a pro-secretory effect 
of H2S in the human colon. This effect is mediated by 
capsaicin sensitive nerves, suggesting it activates 
extrinsic afferents to mediate secretion via an axon 
reﬂex. These data show that H2S can cause either 
contraction or relaxation and the actions of H2S might 
be nerve mediated or alternatively a putative effect on 
smooth muscle could be postulated. 
The effects of H2S on an integrated motor pattern 
such as peristalsis have not yet been examined, nor 
have the effects on human GI smooth muscle been 
identiﬁed. In the present experiments, we examined 
the effects of H2S on distension-induced motor 
patterns in the mouse jejunum and colon, and 
subsequently characterized the effects and the 
mechanism of H2S induced relaxation in spontaneous 
contractions in the rat and human colon. 
MATERIALS AND METHODS 
Mouse tissue preparation 
Experiments were performed on isolated segments of 
jejunum and colon from C57Bl6 mice of either sex. To 
examine the role of transient receptor potential of the 
'vanilloid' subfamily (TRPV1), TRPV1)/) animals 
were used.15 Animals were killed by overdose of 
sodium pentobarbital (300 mg kg)1; Sagatal, Rhone 
Poulenc Fr., Dagenham, UK) followed by exsanguina­
tion. All experiments were conducted according to the 
requirements of the United Kingdom Animals (Scien­
tiﬁc Procedures) Act (1986). The abdomen was opened 
and the mid jejunum and distal colon were removed, 
ﬂushed of their contents and placed in oxygenated 
Krebs solution. 
Rat tissue preparation 
Male Sprague–Dawley rats (Charles River, Lyon, 
France), 8–10 weeks old and weighing 300–350 g, were 
used (n = 7). They were kept under conventional 
conditions in an environmentally controlled room 
(20–21 °C, 60% humidity, 12 : 12 h light–dark cycle) 
in groups of three animals and had unlimited access to 
water and food. Before the in vitro studies, rats 
were kept individually and fasted for 16–18 h with 
ad libitum access to water. Animals were decapitated 
and bled. All the experimental protocols were approved 
by the ethical committee of the Universitat Auto`noma 
de Barcelona (Spain). 
The entire colon was carefully removed and placed 
in a dissection dish containing carbogenated Krebs 
solution. The mesenteric fat was removed and the 
colon was opened along the mesenteric border. A small 
segment of mid colon was pinned to a Sylgard base 
with the mucosa facing upwards and the mucosal and 
submucosal layers were gently removed to study 
circular muscle strips. 
Human tissue preparation 
Specimens of distal and sigmoid colon were obtained 
from patients (aged 47–78 years, n = 15) during colon 
resections for neoplasm. Colon segments from macro­
scopically normal regions were collected and trans­
ported to the laboratory in cold saline buffer. The 
tissue was placed in Krebs solution on a dissection dish 
and the mucosal layer was gently removed. Circular 
muscle strips, 10 · 4 mm, were cut. The patients 
provided informed consent and experimental procedure 
was approved by the ethics committee of the Hospital 
of Mataro´ (Barcelona, Spain). 
Mechanical experiments 
Isolated mouse colon and jejunum In the experiments 
with isolated mouse intestine, a 3-cm segment of gut 
was placed in an organ bath (10 mL) perfused with 
warm (36 °C) oxygenated Krebs solution and was 
cannulated at both ends, with a pressure transducer at 
the aboral end. The lumen was distended with saline to 
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a pressure of 2–3 cmH2O, and spontaneous motor 
complexes (MCs) were recorded. Signals were ampli­
ﬁed using a Neurolog NL108 Digitimer, (Welwyn 
Garden City, UK) pressure ampliﬁer, digitized at 
100 Hz using a CED 1401 interface (Cambridge Elec­
tronic Designs, Cambridge, UK) and displayed on a PC 
running SPIKE2 sofware package. 
Drugs were added directly to the bath solution, 
except for a few cases when luminal application of H2S 
was examined. Agonists were perfused for 10 min 
followed by a washout period of 30 min prior to further 
agonist application. Antagonists were added to the bath 
solution 30 min prior to agonist application. The roles 
of endogenous adenosine triphosphate (ATP) and NO 
release were examined using pyridoxal-phosphate-6­
azophenyl-2¢,4¢-disulfonate (PPADS, 30 lmol L)1) and 
Ne-nitro-L-arginine methyl ester (100 lmol L
)1) respec­
tively. The potential role of TRPV1 receptors was 
assessed using TRPV1)/) transgenic mice. To allow 
the examination of direct effects on smooth muscle 
contraction, TTX (1 lmol L)1) was used as it blocks all 
neurally mediated MCs in this preparation. 
Colonic strips Human and rat tissue muscle strips 
were examined in a 10 mL organ bath ﬁlled with Krebs 
solution at 37 ± 1 °C. An isometric force transducer 
(Harvard VF-1 Harvard Aparatus Inc, Holliston, MA, 
USA) connected to an ampliﬁer was used to record the 
mechanical activity. Data were digitized (25 Hz) using 
DATAWIN1 software (Panlab, Barcelona, Spain) coupled 
to an ISC-16 A/D card installed in a PC computer. 
A tension of 4 g was applied to the human tissue and of 
1 g to the rat tissue and they were allowed to equili­
brate for 1 h. After this period, strips displayed spon­
taneous phasic activity. To estimate the responses to 
the drugs, the area under the curve (AUC) of sponta­
neous contractions from the baseline was measured 
before and after drug addition. To normalize data, the 
value of AUC obtained before the treatment was con­
sidered 100 and the percentage of inhibition of the 
spontaneous motility was estimated with the AUC 
obtained after the treatment. 
Solutions and drugs 
The composition of the Krebs solution was (in 
mmol L)1) 10.10 glucose, 115.48 NaCl, 21.90 NaHCO3, 
4.61 KCl, 1.14 NaH2PO4, 2.50 CaCl2 and 1.16 MgSO4 
bubbled with a mixture of 5% CO2 : 95% O2 (pH 7.4). 
The following drugs were used: sodium hydrogen 
sulphide (NaHS), apamin, glybenclamide, tetraethylam­
monium chloride (TEA), capsaicin, ATP, Ne-nitro-L­
arginine methyl ester (L-NAME), bethanechol chloride 
(Sigma Chemicals, St Louis, MO, USA) tetrodotoxin 
(TTX) (Latoxan, Valence, France), PPADS (Tocris, 
Bristol, UK). Stock solutions were made by dissolving 
drugs in distilled water except for glibenclamide which 
was dissolved in DMSO and capsaicin which was 
dissolved in a solution of 80% DMSO/20% Tween 80. 
Data analysis and statistics 
In the mouse-isolated intestine experiments, MCs were 
analysed with respect to peak amplitude (relative to 
basal pressure). The mean amplitude of the ﬁve 
contractions before drug application was considered 
as baseline, and inhibitory effects were expressed as % 
change from baseline. In the human and rat muscle 
strip experiments, cumulative concentration–response 
curves of H2S using NaHS as a donor were calculated to 
estimate the IC50. To normalize data, we calculated the 
percentage inhibition by the drugs considering the 
AUC before the addition of the H2S donor as 100%. H2S 
dose–response curves were performed in control, in the 
presence of TTX and in the presence of neural blockade 
plus potassium channel antagonists. Because of the 
difﬁculty to perform all protocols with the same tissue, 
protocols were randomly performed without repetition 
of the same protocol in the same animal/patient. The 
differences between groups were compared by two-way 
analysis of variance (two-way ANOVA). A P < 0.05 was 
considered statistically signiﬁcant. 'n' values indicate 
the number of animals and patients. Statistical analysis 
was performed with GraphPad Prism version 4.00 
(GraphPad Software, San Diego CA, USA). Data are 
expressed as mean ± SEM. 
RESULTS 
In both the mouse colon and jejunum, bath-applied 
NaHS caused an inhibition of spontaneous MCs 
(Fig. 1A). This effect was dose-dependent, with IC50 
values of 121 lmol L)1 in the colon and 150 lmol L)1 
in the jejunum, and maximal (100%) inhibition occur­
ring between 300 and 1000 lmol L)1 (Fig. 1B). Luminal 
application of NaHS also caused an inhibition of 
motility but the effect was less consistent and required 
higher concentrations compared to bath application. 
For all further experiments, NaHS was directly applied 
to the bath. 
Role of TRPV1 receptors 
As previous work on urinary bladder muscle and 
intestinal secretion has suggested a role for capsaicin 
sensitive nerves in the effects of H2S, we hypothesized 
© 2008 The Authors 
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that TRPV1 channels may be involved in the inhibi­
tory effects of NaHS on spontaneous MCs. In the 
mouse jejunum and colon, capsaicin (100 nmol L)1) 
caused an inhibition of MCs. In contrast, this effect 
was absent in intestine from TRPV1)/) animals. 
However, in both TRPV1+/+ and )/) intestine, NaHS 
caused a similar concentration-dependent inhibition 
with nearly identical concentration–response relation­
ships (n = 6 of each) (Fig. 1C). 
Role of purinergic receptors 
As ATP is an important inhibitory neurotransmitter in 
the intestine, and our own preliminary experiments 
have indicated a role for P2 receptors in H2S-mediated 
excitation of visceral afferent nerves in the mouse 
(unpublished observations), we sought to examine the 
role of endogenously released ATP in the H2S-mediated 
relaxation of jejunal and colonic motility. ATP 
(300 lmol L)1) caused inhibition of MCs, an effect 
that was prevented by 30 lmol L)1 PPADS. In contrast, 
the effect of NaHS (300 lmol L)1) was not signiﬁcantly 
inhibited by PPADS (30 lmol L)1) (80.1 ± 8.8% vs 
76.33 ± 9.3% inhibition P > 0.05, n = 5). 
Role of NO release 
As NO is an important inhibitory neurotransmitter in 
the gut, and because of the evidence, at least in some 
vascular smooth muscles, that NO may mediate some of 
the effects of H2S, we examined the role of NO release 
using the NO-synthase blocker, L-NAME. In the mouse 
jejunum, L-NAME (100 lmol L)1) increased MC ampli­
tude and frequency, while in the colon, MC amplitude 
was inhibited. However in neither region was the 
inhibitory effect of NaHS (300 lmol L)1) attenuated, 
MC amplitude inhibition being similar in both regions 
(74.3 ± 8.9% control vs 80.3 ± 10.1% L-NAME, n = 6). 
© 2008 The Authors 
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Non-neurnal effect of H2S 
To examine the effects of NaHS on smooth muscle 
contraction, independent of neural inﬂuences, we 
blocked intrinsic neurotransmission using TTX 
(1 lmol L)1). This abolished spontaneous MCs and 
increased tone. Under these conditions, NaHS resulted 
in a reduction in basal tone (3.5 ± 0.4 vs 
1.2 ± 0.22 cmH2O; P < 0.05, n = 5). To study the effect 
of NaHS on a pharmacologically induced contraction, 
we examined the effect of perfusing 300 lmol L)1 
NaHS on the contraction induced by 30 lmol L)1 
bethanechol under control conditions. In the presence 
of TTX, bethanechol induced a contraction that par­
tially relaxed during a 5-min perfusion. The amplitude 
of this contraction was signiﬁcantly attenuated in the 
presence of 300 lmol L)1 NaHS. (25.8 ± 6.6 vs 
10.2 ± 3.5; P < 0.05, n = 6). Contraction amplitude 
was restored after washout of NaHS (Fig. 2). 
Effects of NaHS on human and rat colon muscle 
strips 
Sodium hydrogen sulphide concentration-dependently 
inhibited spontaneous motility. In the human colon, 
IC50 was 261 lmol L
)1 (95% conﬁdence interval 
log IC50 = )3.58 ± 0.05; n = 5) and in the rat colon 
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IC50 was 31 lmol L
)1 (95% conﬁdence interval 
log IC50 = )4.5 ± 0.04, n = 6). No major differences 
were found when dose–response curves were performed 
in the presence of the neural blocker TTX (1 lmol L)1). 
In the human, IC50 was 183 lmol L
)1 (95% conﬁdence 
interval log IC50 = )3.73 ± 0.08; n = 5, ns) and in the 
rat colon, IC50 was 26 lmol L
)1 (95% conﬁdence 
interval log IC50 = )4.57 ± 0.04; n = 6, ns) (Fig. 3). 
Role of potassium channels 
Available evidence suggests that some of the effects 
of H2S may be mediated via activation of one or 
more potassium channel subtypes. We therefore 
designed a number of experiments to examine the 
role of K channels in the actions of H2S in the GI 
tract. In the presence of TTX, TEA (10 mmol L)1), a 
K-channel blocker, signiﬁcantly reduced the inhibi­
tory effect induced by H2S. The NaHS IC50 was 
reduced to 2421 lmol L)1 (95% conﬁdence interval 
log IC50 = 2.6 ± 0.06; n = 5,  P < 0.0001) for the 
human colon and 674 lmol L)1 (95% conﬁdence 
interval log IC50 = )3.1 ± 0.04; n = 6,  P < 0.0001) for 
the rat colon. 
In the presence of TTX (1 lmol L)1), the ATP 
sensitive channel blocker glybenclamide (10 lmol L)1) 
signiﬁcantly reduced the inhibitory effect of H2S. 
© 2008 The Authors 
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Figure 3 (A) Mechanical recordings showing the inhibitory effect of cumulative doses of NaHS, a H2S donor (10–3000 lmol L
)1) in  
control conditions and (B) after the incubation with TTX (1 lmol L)1) in the human colon. (C) Mechanical recordings showing the 
inhibitory effect of cumulative doses of NaHS, a H2S donor (1–1000 lmol L
)1) in control conditions and (D) after the incubation 
with TTX (1 lmol L)1) in the rat colon. (E) Dose–response curves. Data are expressed as mean ± SEM. 
Glybenclamide increased the NaHS IC50 to and to 80 lmol L
)1 (95% conﬁdence interval 
2464 lmol L)1 (95% conﬁdence interval log IC50 = log IC50 = )4.0 ± 0.04; n = 6,  P < 0.0001) for the rat 
)2.6 ± 0.1; n = 5,  P < 0.0001) for the human colon colon (Fig. 4). 
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In the presence of TTX, the small conductance 
calcium-activated potassium channel blocker apamin 
(3 lmol L)1) signiﬁcantly reduced the inhibitory effect 
of H2S. Apamin increased the NaHS IC50 to 
1307 lmol L)1 (95% conﬁdence interval log IC50 = 
)2.88 ± 0.07; n = 5,  P < 0.0001) in the human colon 
and to 167 lmol L)1 (95% conﬁdence interval lo­
g IC50 = )3.77 ± 0.06, n = 6,  P < 0.0001) in the rat 
colon (Fig. 5). Based on these results, we examined 
the effect of apamin on the NaHS-induced inhibition of 
MCs in the mouse colon. In the mouse colon prepa­
ration, the inhibitory effect of NaHS on spontaneous 
MCs was signiﬁcantly attenuated by apamin 
(3 lmol L)1). In some cases (Fig. 6), the inhibitory 
effect was converted to the excitation in the presence 
of apamin, suggesting a crucial role for SK channels in 
the effects of NaHS on colonic motility. 
In the presence of TTX, glybenclamide (10 lmol L)1) 
and apamin (3 lmol L)1) had a cumulative effect 
reducing the inhibition caused by NaHS. The IC50 
was 3294 lmol L)1 (95% conﬁdence interval log IC50 = 
)2.51 ± 0.08; n = 5,  P < 0.0001) for the human 
colon and 263 lmol L)1 (95% conﬁdence interval 
log IC50 = )3.57 ± 0.05; n = 6,  P < 0.0001) for the rat 
colon. These results were statistically different from 
those obtained with apamin and glybenclamide alone. 
DISCUSSION 
The toxic gas, hydrogen sulphide, has recently been 
described in a number of tissues as a novel gaseous 
mediator. H2S has been shown to have effects on a 
variety of smooth muscle preparations, including vas­
cular, bladder and intestine. H2S might have several 
putative origins in the GI tract. Enteric neurons 
expressing CBS and CSE have been described4 and 
therefore H2S can be a neurotransmitter in the GI tract. 
However, the release of H2S after neuronal stimulation 
has not still been demonstrated in enteric neurons 
although H2S causes the relaxation of GI smooth 
muscle.16 Other putative sources of H2S is the blood 
or the vascular tissues.1 Moreover, large amounts of 
H2S are present in the intestine and colon. In this 
study, we sought to examine the effects of the H2S 
donor, NaHS on motor patterns in isolated jejunum 
and colon. Our experiments clearly demonstrate that 
1312 Journal compilation © 2008 Blackwell Publishing Ltd 
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Figure 4 (A) Mechanical recordings showing the inhibitory effect of cumulative doses of NaHS, a H2S donor (10–3000 l
)mol L 1) 
after the incubation with glybenclamide (10 l )mol L 1) in the human colon. (B) Mechanical recordings showing the inhibitory effect 
)of cumulative doses of NaHS, a H2S donor (1–1000 lmol L
1 )) after the incubation with glybenclamide (10 lmol L 1) in the rat 
colon. (C) Dose–response curves. Data are expressed as mean ± SEM. 
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NaHS, at physiologically relevant concentrations, 
inhibits spontaneous MCs in the isolated jejunum 
and colon. These effects are not mediated by TRPV1 
receptors on capsaicin sensitive nerves (as suggested in 
bladder, and GI secretory effects) nor are they exclu­
sively dependent on endogenous inhibitory reﬂexes 
utilizing NO or ATP. We have however shown that 
NaHS inhibits motility largely through an action on 
multiple potassium channels. 
Work by Pattachini et al.12 has demonstrated that in 
isolated urinary bladder muscle NaHS caused contrac­
tion that was abolished by capsaicin pretreatment. 
Furthermore, the effects of NaHS were similar to that 
of capsaicin, and could be blocked by neurokinin 
antagonists. These observations taken together were 
interpreted to suggest that NaHS stimulated endoge­
nous capsaicin sensitive nerves, resulting in tachyki­
nin release and subsequent smooth muscle 
contraction. Recent work by Schichio et al.4 has also 
demonstrated a pro-secretory effect of H2S in the 
rodent and human colon as well as stimulation of 
enteric nerves. Capsaicin sensitive nerves were also 
implicated in these effects. This raised the possibility 
that NaHS might act via the capsaicin receptor, 
TRPV1. Indeed, in our experiments, capsaicin inhibited 
MCs, in a similar way to NaHS. However, utilizing 
TRPV1-deﬁcient mice, we found that the effects of 
NaHS were almost identical to the wildtype controls. 
Experiments performed by Pataccini et al.17 showed 
that the effects of NaHS in bladder could not be 
blocked by the TRPV1 antagonists capsazepine and 
SB366791, however, the effect of NaHS was antago­
nized with ruthenium red. The authors suggested that 
this raised the possibility of an action on TRPV1 
receptors at a novel site or other TRP channels. In a 
separate study, TRPV1 antagonists attenuated NaHS­
induced neurogenic inﬂammation in the lung.18 How­
ever, our experiments with transgenic mice effectively 
rule out a role for the TRPV1 receptor in mediating 
NaHS inhibition of motility, at least in the mouse 
intestine; our results here point to other mechanisms 
of action. 
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Previous work on vascular smooth muscle has 
suggested that NO may mediate or synergize with 
the effects of H2S.
19 Given that NO is one of the most 
important inhibitory neurotransmitters in the gut, we 
examined its role in the inhibition of peristalsis 
induced by NaHS. At a concentration that effectively 
blocked endogenous NO synthase, L-NAME altered 
peristaltic contractions in the jejunum and colon in 
different ways. In the jejunum, contraction amplitude 
and frequency were increased, as was basal tone. In 
contrast, in the colon, contraction amplitude was 
decreased. The reasons for these regional differences 
are not clear. Powell et al.20 have made a similar 
observation in the mouse colon using another NOS 
inhibitor. It may be that in the jejunum NO plays a 
predominantly inhibitory role while in the colon NO 
may activate some excitatory neural circuits itself, 
or mediate a postinhibitory 'rebound' contraction. 
Another possibility is that NO excites the longitudinal 
muscle, as has been demonstrated in the oesophagus.21 
Nonetheless, despite alterations in their basal motility 
patterns, L-NAME failed to prevent the inhibition of 
peristalsis by NaHS, suggesting that endogenous NO 
does not play a major role in NaHS-induced inhibition. 
ATP is increasingly recognized as an important 
inhibitory neurotransmitter in the gut. Acting through 
P2Y receptors it mediates a fast inhibitory junction 
potential.22–24 Furthermore, ATP release can be stim­
ulated by a variety of noxious stimuli in the viscera 
(e.g. distention, hypoxia, etc.).25 Our own results show 
that exogenous ATP can inhibit MCs in the jejunum 
and colon. Additional preliminary data suggest that 
H2S can excite intestinal afferent ﬁbres, in part via 
ATP release, and an action on PPADS sensitive 
receptors. We therefore examined the effects of PPADS 
on NaHS inhibition of MCs. At concentrations that 
prevent the inhibition of MCs by exogenous ATP, 
NaHS had no inhibitory effect on MCs suggesting that 
ATP does not mediate the inhibitory effects. 
There is a recent literature suggesting that H2S may 
directly inhibit the contraction in a variety of smooth 
muscle such as bladder, vascular, and in ileal smooth 
muscle strips.13 To examine this possibility in our 
preparation, we blocked neurally mediated MCs with 
TTX, thus permitting examination of the direct 
effects on smooth muscle. Under these conditions, 
H2S inhibited basal tone and the contraction evoked 
by the muscarinic agonist bethanechol. Subsequently, 
utilizing muscle strips from the rat and human colon, 
we used a number of pharmacological approaches to 
examine the ionic mechanism of action of H2S on  
these tissues. Blockade of potassium channels with 
the non-selective potassium channel blocker TEA 
resulted in signiﬁcant attenuation of the inhibitory 
effect of NaHS. This led us to utilize more selective 
blockers of speciﬁc potassium channel families. The 
selective calcium activated SK-channel blocker apam­
in resulted in signiﬁcant inhibition of the relaxant 
effects of NaHS. In some cases, the inhibitory effect 
was converted by apamin to an excitatory one. In 
addition, glybenclamide, a KATP channel antagonist, 
also signiﬁcantly diminished the inhibitory effect of 
NaHS. The interpretation of these results should be 
cautious because potassium channels are also in­
volved in the control of the resting membrane 
potential and an increase in motility is often observed 
after potassium channel blockade. The displacement 
of the curve might also be attributable to the modi­
ﬁcation of the resting conditions. In this sense, the 
effect of glybenclamide is greater in human than in rat 
tissue and this might be related to the higher increase 
in spontaneous motility observed in human than in 
rats. However, when TTX is added or NOS is inhib­
ited by L-NAME an increase in motility is usually 
observed (more prominent in rats) and the effect of 
H2S is not modiﬁed. Moreover, the important shift of 
the curves found in presence of TEA or the combina­
tion of both apamin and glybenclamide strongly 
suggest the involvement of potassium channels on 
the H2S response. These results agree with those in 
vascular smooth muscle and in the rabbit ileum.13 It 
appears from our experiments here that the relaxant 
© 2008 The Authors 
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effect of H2S in human and rodent GI smooth muscle 
is direct via the activation of K channels possibly 
located in smooth muscle.26,27 The reduction in the 
frequency of spontaneous contraction after NaHS 
addition suggests a putative action of H2S in K  
channels located in interstitial cells of Cajal 
(ICC),28,29 an alternative which should be considered 
in future experiments. Interestingly, in the isolated 
mouse colon preparation, in some cases, in the 
presence of apamin, an excitatory effect of NaHS 
was unmasked. The mechanism remains to be deter­
mined, however, the action of NaHS may depend 
critically on the relative balance between inhibitory 
and excitatory actions. The ﬁnding of an important 
role for calcium-activated potassium channels sug­
gests that increase in intracellular calcium may be 
important and may explain the ﬁnding of excitation in 
the presence of apamin. The source of this intracel­
lular calcium rise remains to be determined. Further 
experiments using intracellular microelectrode and 
patch clamp techniques are needed to characterize 
fully the ionic mechanisms underlying H2S-induced 
smooth muscle relaxation and putative prejunctional 
or postjunctional actions of H2S including the effect 
on ICCs and smooth muscle should be further studied 
with electrophysiological techniques. 
The ﬁnding that H2S is a potent inhibitor of motility 
is perhaps surprising, given the large quantities present 
in the GI tract. Our experiments, however, demon­
strated that luminal application of NaHS inhibited 
motility far less effectively and consistently than bath 
application. This suggests that, even in the jejunum, 
the mucosa serves as a particularly effective barrier 
to the diffusion of H2S across to the muscle layers. 
Indeed, the colonic mucosa is endowed with an 
efﬁcient H2S-detoxifying mechanism, oxidizing more 
than 300 lmol of H2S to thiol compounds daily in the 
rat colon.7 However, when this barrier is broken down, 
such as in severe colitis, a greater amount of H2S may 
access the muscle layers and inhibit motility, possibly 
becoming clinically relevant in conditions such as 
toxic megacolon, which can complicate severe colitis. 
It is of particular interest that H2S has been implicated 
in the pathogenesis of acute pancreatitis and lipopoly­
saccharide-induced systemic inﬂammation, two condi­
tions known to be associated with increased gut 
permeability and bacterial translocation.14,30,31 Recent 
work has also demonstrated an antinociceptive effect of 
NaHS in the colon.32 How much of this is due to 
muscle relaxation is not clear. These investigators did 
not ﬁnd a change in compliance of the bowel but did 
not carry out detailed investigation of the biomechan­
ical properties. 
In summary, our studies have demonstrated a novel 
inhibitory action of H2S on rodent and, now for the ﬁrst 
time, human colonic motility. The inhibitory action of 
H2S appears to be critically dependent on K channels, 
particularly apamin-sensitive SK channels and glyben­
clamide-sensitive KATP channels. Our results are 
obtained from the small intestine and colon and it is 
important to perform future studies in other areas of 
the GI tract where H2S might be a putative neuro­
transmitter or alternatively where sources of luminal 
H2S are important. These observations may have 
physiological and pathophysiological relevance in con­
ditions where H2S production is increased or where 
barrier or detoxiﬁcation mechanisms are impaired. 
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